Unilabs ("Unilabs"), a leading international provider of diagnostic services, and C2N Diagnostics, LLC ("C2N"), a pioneer in advanced diagnostic solutions in the field of Alzheimer's disease...
C2N Diagnostics, a leader in advanced brain health diagnostics, is closely tracking decision by the U.S. Food and Drug Administration to approve donanemab for...
C2N Diagnostics, a leader in advanced brain health diagnostics, announced the release of the PrecivityAD2 blood test, a clinical care assay that meets the...
C2N Diagnostics, a leader in advanced brain health diagnostics, announced the presentation of two research studies at the AD/PD 2023 International Conference on Alzheimer’s...
C2N Diagnostics and Eisai Inc. announced the Companies have entered into a memorandum of understanding that will seek to build awareness about how blood-based...
